The PPARγ agonists ciglitazone, troglitazone and 15d-PGJ2 and the PPARα ligand WY-14643 were tested on four melanoma cell lines (A375, M24met, 1205Lu and MelJuso) to generalize our findings. Here, PPARG is linked to melanoma.